Literature DB >> 16093289

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

Roberta B Ness1, Kevin E Kip, Sharon L Hillier, David E Soper, Carol A Stamm, Richard L Sweet, Peter Rice, Holly E Richter.   

Abstract

Controversy surrounds the association between bacterial vaginosis (BV) and pelvic inflammatory disease (PID). Women (N = 1,140) were ascertained at five US centers, enrolled (1999-2001), and followed up for a median of 3 years. Serial vaginal swabs were obtained for Gram's stain and cultures. PID was defined as 1) histologic endometritis or 2) pelvic pain and tenderness plus oral temperature >38.8 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood cell count >10,000, or gonococcal/chlamydial lower genital infection. Exploratory factor analysis identified two discrete clusters of genital microorganisms. The first correlated with BV by Gram's stain and consisted of the absence of hydrogen peroxide-producing lactobacillus, Gardnerella vaginalis, Mycoplasma hominis, anaerobic gram-negative rods, and, to a lesser degree, Ureaplasma urealyticum. The second, unrelated to BV by Gram's stain, consisted of Enterococcus species and Escherichia coli. Being in the highest tertile in terms of growth of BV-associated microorganisms increased PID risk (adjusted rate ratio = 2.03, 95% confidence interval: 1.16, 3.53). Carriage of non-BV-associated microorganisms did not increase PID risk. Women with heavy growth of BV-associated microorganisms and a new sexual partner appeared to be at particularly high risk (adjusted rate ratio = 8.77, 95% confidence interval: 1.11, 69.2). When identified by microbial culture, a combination of BV-related microorganisms significantly elevated the risk of acquiring PID.

Entities:  

Mesh:

Year:  2005        PMID: 16093289     DOI: 10.1093/aje/kwi243

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  101 in total

1.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

Review 2.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

Review 4.  Microbiota restoration: natural and supplemented recovery of human microbial communities.

Authors:  Gregor Reid; Jessica A Younes; Henny C Van der Mei; Gregory B Gloor; Rob Knight; Henk J Busscher
Journal:  Nat Rev Microbiol       Date:  2010-11-29       Impact factor: 60.633

5.  Baseline cluster membership demonstrates positive associations with first occurrence of multiple gerontologic outcomes over 10 years.

Authors:  Samah J Fodeh; Mark Trentalange; Heather G Allore; Thomas M Gill; Cynthia A Brandt; Terrence E Murphy
Journal:  Exp Aging Res       Date:  2015       Impact factor: 1.645

6.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

7.  Diversity of cervicovaginal microbiota associated with female lower genital tract infections.

Authors:  Zongxin Ling; Xia Liu; Xiaoyi Chen; Haibin Zhu; Karen E Nelson; Yaxian Xia; Lanjuan Li; Charlie Xiang
Journal:  Microb Ecol       Date:  2011-02-02       Impact factor: 4.552

Review 8.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

9.  Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.

Authors:  David N Fredricks; Tina L Fiedler; Katherine K Thomas; Caroline M Mitchell; Jeanne M Marrazzo
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

10.  Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.

Authors:  B Wang; B B Xiao; C G Shang; K Wang; R S Na; X X Nu; Q Liao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.